Performance vs S&P 500

03
Tracked Q1 2025–Q3 2025 +43.0%
S&P 500 total return (same window) +21.3%
Excess return +21.8%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Health Care 100.0%

Full portfolio 2 positions

05
Type Streak 8Q trend
SGHT Sight Sciences, Inc. - Common Stock $15,049,914 99.66% 4,374,975 $-3,018,733
RNTX Rein Therapeutics, Inc. - Common Stock $52,055 0.34% 22,341 $-196,824

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
SGHT Price move only +0 -$3.0M
RNTX Price move only +0 -$197K